Related Experiment Videos
[Arterial thrombotic complications in Crohn's disease]
P Chamouard1, B Duclos, M Weill-Bousson
1Service d'Hépato-Gastroentérologie et d'Assistance Nutritive, CHU Hautepierre, Strasbourg.
Insights
This study reports four cases of arterial thrombosis in young women with active Crohn's disease. Anticoagulants may be considered for highly active Crohn's disease without bleeding risks.
Area of Science:
- Gastroenterology
- Vascular Medicine
- Rheumatology
Background:
- Crohn's disease (a chronic inflammatory bowel disease) is associated with an increased risk of thrombotic events.
- Arterial thrombosis is a less common but potentially severe complication compared to venous thrombosis in Crohn's disease patients.
Observation:
- The study details four cases of arterial thrombosis, including two cerebral artery events, in young women with highly active Crohn's disease.
- These patients lacked typical atheroma risk factors, and three experienced extraintestinal manifestations.
- Multiple thrombotic episodes occurred in two patients.
Findings:
- Highly active Crohn's disease, particularly with extraintestinal manifestations, may indicate a heightened risk for arterial thrombosis.
- Prophylactic anticoagulation might be beneficial in Crohn's disease patients with highly active disease and no hemorrhagic lesions.
Implications:
- Further research is needed to precisely identify high-risk populations for arterial thrombosis in Crohn's disease.
- Early recognition and management of thrombotic risks are crucial for improving outcomes in Crohn's disease patients.
Abstract:
In a series of 230 observations of Crohn's disease, the authors describe 4 cases of arterial thrombosis; two of them involving cerebral arteries. These complications occurred in young women without any notable risk factor for atheroma. All patients had highly active Crohn's disease when arterial thrombosis occurred: two of them had several episodes of thrombosis and three, extraintestinal manifestations. As the arterial thromboses are often severe, rarely foreseeable and the venous thromboses frequent, the point is whether to use anticoagulants. When Crohn's disease is highly active, but only if there are no hemorrhagic lesions, anticoagulants at prophylactic doses may be recommended. How to define more exactly a high risk thromboses population deserves further investigation.